Report Detail
Global Dengue Vaccine Market Research Report 2019
- RnM3086901 |
- 15 July, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Dengue Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dengue Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dengue Vaccine market is segmented into
CYD-TDV
DENVax or TAK-003
TetraVax-DV
TDENV PIV
V180
DNA vaccines
Segment by Application, the Dengue Vaccine market is segmented into
Government institutions
Hospitals
NGOs
Regional and Country-level Analysis
The Dengue Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dengue Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dengue Vaccine Market Share Analysis
Dengue Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dengue Vaccine business, the date to enter into the Dengue Vaccine market, Dengue Vaccine product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
U.S NIH
Vabiotec
1 Study Coverage
- 1.1 Dengue Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Dengue Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type
- 1.4.2 CYD-TDV
- 1.4.3 DENVax or TAK-003
- 1.4.4 TetraVax-DV
- 1.4.5 TDENV PIV
- 1.4.6 V180
- 1.4.7 DNA vaccines
- 1.5 Market by Application
- 1.5.1 Global Dengue Vaccine Market Size Growth Rate by Application
- 1.5.2 Government institutions
- 1.5.3 Hospitals
- 1.5.4 NGOs
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dengue Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global Dengue Vaccine Revenue 2015-2026
- 2.1.2 Global Dengue Vaccine Sales 2015-2026
- 2.2 Global Dengue Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Dengue Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Dengue Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dengue Vaccine Competitor Landscape by Players
- 3.1 Dengue Vaccine Sales by Manufacturers
- 3.1.1 Dengue Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Dengue Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Dengue Vaccine Revenue by Manufacturers
- 3.2.1 Dengue Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Dengue Vaccine Revenue in 2019
- 3.2.5 Global Dengue Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Dengue Vaccine Price by Manufacturers
- 3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dengue Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Dengue Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Dengue Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Dengue Vaccine Revenue by Type (2015-2020)
- 4.1.3 Dengue Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Dengue Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Dengue Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Dengue Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Dengue Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Dengue Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Dengue Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Dengue Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Dengue Vaccine Revenue by Application (2015-2020)
- 5.1.3 Dengue Vaccine Price by Application (2015-2020)
- 5.2 Dengue Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Dengue Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Dengue Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Dengue Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Dengue Vaccine by Country
- 6.1.1 North America Dengue Vaccine Sales by Country
- 6.1.2 North America Dengue Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Dengue Vaccine Market Facts & Figures by Type
- 6.3 North America Dengue Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Dengue Vaccine by Country
- 7.1.1 Europe Dengue Vaccine Sales by Country
- 7.1.2 Europe Dengue Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dengue Vaccine Market Facts & Figures by Type
- 7.3 Europe Dengue Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Dengue Vaccine by Region
- 8.1.1 Asia Pacific Dengue Vaccine Sales by Region
- 8.1.2 Asia Pacific Dengue Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Dengue Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Dengue Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Dengue Vaccine by Country
- 9.1.1 Latin America Dengue Vaccine Sales by Country
- 9.1.2 Latin America Dengue Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Dengue Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Dengue Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Dengue Vaccine by Country
- 10.1.1 Middle East and Africa Dengue Vaccine Sales by Country
- 10.1.2 Middle East and Africa Dengue Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Dengue Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Dengue Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description and Business Overview
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
- 11.1.5 GlaxoSmithKline Related Developments
- 11.2 Merck Sharp & Dohme
- 11.2.1 Merck Sharp & Dohme Corporation Information
- 11.2.2 Merck Sharp & Dohme Description and Business Overview
- 11.2.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered
- 11.2.5 Merck Sharp & Dohme Related Developments
- 11.3 Sanofi
- 11.3.1 Sanofi Corporation Information
- 11.3.2 Sanofi Description and Business Overview
- 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Sanofi Dengue Vaccine Products Offered
- 11.3.5 Sanofi Related Developments
- 11.4 Takeda Pharmaceuticals
- 11.4.1 Takeda Pharmaceuticals Corporation Information
- 11.4.2 Takeda Pharmaceuticals Description and Business Overview
- 11.4.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered
- 11.4.5 Takeda Pharmaceuticals Related Developments
- 11.5 GeneOne Life Sciences
- 11.5.1 GeneOne Life Sciences Corporation Information
- 11.5.2 GeneOne Life Sciences Description and Business Overview
- 11.5.3 GeneOne Life Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered
- 11.5.5 GeneOne Life Sciences Related Developments
- 11.6 Medigen Biologics
- 11.6.1 Medigen Biologics Corporation Information
- 11.6.2 Medigen Biologics Description and Business Overview
- 11.6.3 Medigen Biologics Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Medigen Biologics Dengue Vaccine Products Offered
- 11.6.5 Medigen Biologics Related Developments
- 11.7 Panacea Biotec
- 11.7.1 Panacea Biotec Corporation Information
- 11.7.2 Panacea Biotec Description and Business Overview
- 11.7.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Panacea Biotec Dengue Vaccine Products Offered
- 11.7.5 Panacea Biotec Related Developments
- 11.8 Sun Pharmaceutical
- 11.8.1 Sun Pharmaceutical Corporation Information
- 11.8.2 Sun Pharmaceutical Description and Business Overview
- 11.8.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered
- 11.8.5 Sun Pharmaceutical Related Developments
- 11.9 U.S NIH
- 11.9.1 U.S NIH Corporation Information
- 11.9.2 U.S NIH Description and Business Overview
- 11.9.3 U.S NIH Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 U.S NIH Dengue Vaccine Products Offered
- 11.9.5 U.S NIH Related Developments
- 11.10 Vabiotec
- 11.10.1 Vabiotec Corporation Information
- 11.10.2 Vabiotec Description and Business Overview
- 11.10.3 Vabiotec Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Vabiotec Dengue Vaccine Products Offered
- 11.10.5 Vabiotec Related Developments
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description and Business Overview
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
- 11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Dengue Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Dengue Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Dengue Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Dengue Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Dengue Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Dengue Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Dengue Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Dengue Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Dengue Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Dengue Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Dengue Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Dengue Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Dengue Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Dengue Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Dengue Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Dengue Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Dengue Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Dengue Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Dengue Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Dengue Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dengue Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dengue Vaccine. Industry analysis & Market Report on Dengue Vaccine is a syndicated market report, published as Global Dengue Vaccine Market Research Report 2019. It is complete Research Study and Industry Analysis of Dengue Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
